Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner.
about
The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseCotransfer of regulatory T cells improve the therapeutic effectiveness of mesenchymal stem cells in treating a colitis mouse modelRegulatory T cells in multiple sclerosis and myasthenia gravis.In vivo kinetics and nonradioactive imaging of rapidly proliferating cells in graft-versus-host diseaseAttenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of TregAutophagy-dependent regulatory T cells are critical for the control of graft-versus-host disease.Ex vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future.Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.T regulatory cell mediated immunotherapy for solid organ transplantation: A clinical perspective.Bronchiolitis obliterans syndrome in adults after allogeneic stem cell transplantation-pathophysiology, diagnostics and treatment.The Why, what, and How of the New FACT standards for immune effector cells.Patients with Treatment-Requiring Chronic Graft versus Host Disease after Allogeneic Stem Cell Transplantation Have Altered Metabolic Profiles due to the Disease and Immunosuppressive Therapy: Potential Implication for Biomarkers.B-cell targeting in chronic Graft-versus-Host disease.Cytokine mediators of chronic graft-versus-host disease.MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice.Invariant natural killer T cells ameliorate murine chronic GVHD by expanding donor regulatory T cells.T Follicular Regulatory Cells and Antibody Responses in TransplantationImpaired bone marrow B-cell development in mice with a bronchiolitis obliterans model of cGVHD
P2860
Q28076264-A3258FD6-1604-45F2-9652-804FC8CF12AEQ33621594-FDA3AB66-C41C-4517-AC58-4BB3DECB7E1EQ33784969-82FDBD01-84EB-4C40-BDA3-9384AE6250C4Q33798249-DDEEA9A8-AF66-451E-9577-F2B95B9CE48CQ33804224-6019E34A-BE6C-403E-B482-73B1365559FFQ37277015-BEB9BF7A-FAA1-4A0F-BB4A-F8A0FB5BB472Q38742867-69341F87-3A7E-4401-9287-824DA432CB19Q39002164-D1EE5781-4B3C-45D2-BD37-A0BA85773793Q39017604-89F5EA23-DF4E-41AF-B503-AB7A09CFA7D0Q40385568-A3A1B7AD-C727-4C4F-A147-FCCE12A03471Q42362162-37A2EB52-DDF2-4B4C-BAB1-03B6BC9FDB25Q49464975-820CBC21-475C-43E5-968C-F74C1620BCBEQ50044417-B248EF11-9334-448C-8D99-8D82E7DCA97DQ50915048-0EF44D0A-D97D-49E2-ABF6-74A724E57037Q52659696-54D024CB-F343-4594-BE60-F4710298A533Q52776444-A373B482-2A60-4AFF-B3F0-DA4B7EE42BC8Q57146361-43487105-0999-49A4-9C3E-E614316E19EBQ58723868-A571C50A-608C-49DC-A90A-AA2F4613CC82
P2860
Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Therapeutic regulatory T-cell ...... D in a CXCR5-dependent manner.
@en
type
label
Therapeutic regulatory T-cell ...... D in a CXCR5-dependent manner.
@en
prefLabel
Therapeutic regulatory T-cell ...... D in a CXCR5-dependent manner.
@en
P2093
P2860
P50
P1433
P1476
Therapeutic regulatory T-cell ...... D in a CXCR5-dependent manner.
@en
P2093
Angela Panoskaltsis-Mortari
Bruce R Blazar
Corey S Cutler
Jerome Ritz
John Koreth
Jonathan S Serody
Joseph H Antin
Laurence A Turka
Leo Luznik
Nicholas Peterson
P2860
P304
P356
10.1182/BLOOD-2016-05-715896
P407
P577
2016-07-06T00:00:00Z